C07D 233/04
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other
Official title: having one double bond between ring members or between a ring member and a non-ring member
C07D233/04 (Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other) appears on 1,862 US grants and 1,270 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,862
- Published applications
- 1,270
- Assignees
- 870
- Inventors
- 4,978
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 53 | 0 |
| 1977 | 41 | 0 |
| 1978 | 51 | 0 |
| 1979 | 35 | 0 |
| 1980 | 48 | 0 |
| 1981 | 57 | 0 |
| 1982 | 42 | 0 |
| 1983 | 30 | 0 |
| 1984 | 28 | 0 |
| 1985 | 34 | 0 |
| 1986 | 37 | 0 |
| 1987 | 29 | 0 |
| 1988 | 25 | 0 |
| 1989 | 30 | 0 |
| 1990 | 24 | 0 |
| 1991 | 27 | 0 |
| 1992 | 28 | 0 |
| 1993 | 28 | 0 |
| 1994 | 23 | 0 |
| 1995 | 34 | 0 |
| 1996 | 25 | 0 |
| 1997 | 30 | 0 |
| 1998 | 50 | 0 |
| 1999 | 44 | 0 |
| 2000 | 43 | 0 |
| 2001 | 42 | 9 |
| 2002 | 60 | 55 |
| 2003 | 46 | 83 |
| 2004 | 38 | 77 |
| 2005 | 35 | 76 |
| 2006 | 45 | 59 |
| 2007 | 33 | 54 |
| 2008 | 34 | 54 |
| 2009 | 36 | 63 |
| 2010 | 37 | 62 |
| 2011 | 44 | 57 |
| 2012 | 39 | 41 |
| 2013 | 42 | 47 |
| 2014 | 49 | 47 |
| 2015 | 47 | 43 |
| 2016 | 40 | 53 |
| 2017 | 46 | 38 |
| 2018 | 29 | 51 |
| 2019 | 37 | 38 |
| 2020 | 35 | 61 |
| 2021 | 28 | 40 |
| 2022 | 35 | 41 |
| 2023 | 22 | 39 |
| 2024 | 30 | 35 |
| 2025 | 19 | 34 |
| 2026 | 18 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Highly pure phentolamine mesylate and methods for making same15 Sep 2026US 12,735,389 B2Opus Genetics, Inc.
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- α1A-adrenergic receptor agonists and methods of use1 Sep 2026US 12,723,038 B2CuraSen Therapeutics, Inc.
- Substituted oxazolidinones and imidazolinones as herbicides24 Sep 2026US 2026/0285850 A1FMC Corporation
- Novel fungal derived compounds20 Aug 2026US 2026/0242430 A1Aalborg Universitet
- Pourable wetting agents and methods associated therewith13 Aug 2026US 2026/0234462 A1Aramco Americas Company
- One step reaction for the catalytic synthesis of cyclic urea derivatives30 Jul 2026US 2026/0217658 A1Huntsman Petrochemical Corporation
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
Most cited
By later US patents
- Spatially-addressable immobilization of anti-ligands on surfaces486US 5,252,743 AAffymax Technologies N.V. · 1993
- Spatially-addressable immobilization of anti-ligands on surfaces283US 5,451,683 AAffymax Technologies N.V. · 1995
- 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation222US 5,616,601 AG. D. Searle & Co. · 1997
- Spatially-addressable immobilization of anti-ligands on surfaces211US 5,482,867 AAffymax Technologies N.V. · 1996
- Softening and conditioning fibers with imidazolinium compounds149US 4,720,383 AQuaker Chemical Corporation · 1988